Where is Health Technology Assessment Going?

Hosted By: Pharma IQ
Rate this Podcast: 
Average: 5 (1 vote)
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Chrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher discusses how she sees health economists and statisticians interacting going forwards, why there is so much emphasis on reporting for reimbursement and whether she expects pharma companies will try and do this more in-house, in the future. Fletcher also offers her thoughts on health economists who do not have a statistical background, how she sees the HTA evolving and its place in the next 5-10 years.


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018